Profound Medical logo
Profound Medical
PROF | NASDAQ
Chart Builder DCF Calculator
$7.34
-$0.08 (-1.08%)
At close: Nov 16, 2026, 4:00 PM ET
$7.20
-$0.14 (-1.91%)
After-hours: Nov 16, 2026, 7:30 PM ET

Profound Medical Company Profile

Company profile explained

Company Profile

Profound Medical Corp., through its subsidiaries, is a commercial-stage medical technology firm specializing in the development of magnetic resonance (MR)-guided ablation solutions. These innovative procedures are designed to treat conditions such as prostate disease and uterine fibroids, as well as providing palliative pain relief. The company markets its solutions across Canada, Germany, the United States, and Finland. Its flagship product, the TULSA-PRO system, is specifically designed for use with magnetic resonance imaging (MRI) scanners within hospital settings and other treatment centers. Additionally, Profound Medical offers Sonalleve, a therapeutic platform that addresses uterine fibroids – including through non-invasive methods – and provides palliative relief for pain linked to bone metastases. The company's primary operations are headquartered in Mississauga, Canada.

Key Executives

Name Position
Arun Swarup Menawat Chairman of the Board & Chief Executive Officer
Mathieu Burtnyk Chief Technology Officer
Matthew Sobczyk Interim Chief Financial Officer
Levant Tinaz Software Developer
Richard R. Fabian President
Stephen Kilmer Investor Relations
Thomas Tamberrino Chief Commercial Officer

Latest SEC Filings

Date Type Title
Oct 22, 2026 8-K Current Report
Oct 14, 2026 8-K Current Report
Oct 09, 2026 8-K Current Report
Oct 07, 2026 8-K Current Report
Sep 04, 2026 8-K Current Report
Sep 03, 2026 8-K Current Report
Aug 17, 2026 8-K Current Report
Aug 17, 2026 8-K Current Report
Aug 13, 2026 8-K Current Report
Aug 06, 2026 10-Q Quarterly Report
View All SEC Filings ➞
Profound Medical
Profound Medical logo
Country Canada
IPO Date Oct 29, 2019
Industry Medical - Devices
Sector Healthcare
Employees 162
CEO Arun Swarup Menawat

Contact Details

2400 Skymark Avenue Mississauga, ON L4W 5K5 Canada

Stock Details

Ticker Symbol PROF
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001628808
CUSIP Number 74319B502
ISIN Number CA74319B5027
SIC Code 3841

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.